A copy of the R&D Day presentation can be found here. About Primary Sclerosing Cholangitis Primary Sclerosing Cholangitis (PSC) is a rare, progressive, cholestatic, immune‐mediated disease of ...

today announced that the Company plans to highlight new research supporting its lead development candidates for the treatment of primary sclerosing cholangitis (PSC), a rare and progressive liver ...

April 24, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that the Company plans to highlight new research supporting its lead development candidates for the treatment of primary ...

A copy of the R&D Day presentation can be found here . Primary Sclerosing Cholangitis (PSC) is a rare, progressive, cholestatic, immune‐mediated disease of the bile ducts. Bile ducts carry the ...

A Fife woman has spoken about her experience of living with a rare liver disease which made her feel “like bugs were crawling" on her body. Mo Christie, 54, was diagnosed with primary biliary ...

for the treatment of patients with primary sclerosing cholangitis (PSC) will be presented at major upcoming scientific conferences including DDW25, Digestive Disease Week 2025 ®; EASL 2025, the Annual ...

Ipsen has been given accelerated approval by the FDA for Iqirvo, which becomes the first dual PPAR alpha/delta agonist for rare cholestatic liver disease primary biliary cholangitis (PBC).

Most people have never heard of primary biliary cholangitis (PBC), but the progressive, rare cholestatic liver disease can ...

At the start of the year, there had been no new therapies for rare cholestatic liver disease primary biliary cholangitis (PBC) in the US for almost a decade. With the FDA approval of Gilead's ...

Senate Majority Leader Jack Johnson pushes bill to enshrine primary voting while advocacy group Tennessee Stands argues caucuses better protect party interests. NASHVILLE, Tenn. (WTVF ...

Cirrhosis progresses in stages, from a compensated phase with few symptoms to a decompensated phase with serious ...